Participate in Research

Clinical Trial for People Diagnosed with Mild Cognitive Impairment
Protocol: STUDY00007445
Full Title
Metformin in Alzheimer's dementia Prevention (MAP)
The University at Buffalo (UB) Department of Neurology is conducting a clinical trial for adults diagnosed with mild cognitive impairment (MCI). The goal of the study is to see if the study drug (metformin) can help to prevent the worsening of thinking and memory for people living with MCI.

Participants will be enrolled in the study for at least 22 months. They will complete 4 in-person visits and have the option of completing 2 additional visits for brain imaging. They will also have physical exams, lab tests, blood draws, and complete surveys throughout the study. Participants will receive $50 for completing a screening visit and $200 for each of the 4 study visits and optional braining imaging visits.
Compensation: Yes
Compensation may include cash, checks, gift cards, debit cards, or incentives like gift baskets, technology items, or merchandise.
Adults 55 to 90 years old You are experiencing memory loss or have been diagnosed with mild cognitive impairment (MCI) Have not been diagnosed with diabetes
Age Group: Adults
Principal Investigator: KINGA SZIGETI Open Study
Want to Learn More?

Let us know how the study team can reach you. If you do not hear back within 2 business days, then reach out to the study team directly at the contact information above and someone will assist you.

Your information will be shared only with the research study team and administrative staff for recruitment and will remain confidential. Your information will be stored until study recruitment is closed. Should you no longer want this information to be provided in the aforementioned ways, please contact the study team directly.

Study teams can login to review submissions